Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Viral Vector Manufacturing Markets and Technologies through 2022 -

Research and Markets
Posted on: 22 Oct 18

The "Global Viral Vector Manufacturing Markets and Technologies Through 2022" report has been added to's offering.

The scope of this report is broad and covers various types of products available, ongoing research and development in the viral vector vaccine manufacturing market, and potential application sectors across various industries. The viral vector vaccine manufacturing market is broken down by types, application and diseases. Revenue forecasts from 2017 to 2022 are given for each product type, application and diseases with estimated valued derived from the revenue of manufacturers' total revenues.

The report also includes a discussion of the major players across each regional viral vector vaccine manufacturing market. Further, it explains the major drivers and regional dynamics of the global viral vector vaccine manufacturing market and current trends within the industry.

The report concludes with a special focus on the vendor landscape and includes detailed profiles of the major vendors in the global viral vector vaccine manufacturing market.

The Report Includes:

  • Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Information on major drivers and regional dynamics of the global viral vector vaccine manufacturing market and current trends within the industry
  • Insight into pipeline products that are manufactured using viral vector tools and technology, and a relevant patent analysis
  • Company profiles of major market players including Advanced Bioscience Laboratories Inc., Boehringer Ingelheim Gmbh, Brammer Bio Llc, Creative Biogene, GE Healthcare, Pfizer Inc., Sanofi SA, and Spark Therapeutics Inc.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary And Highlights

Chapter 3 Market And Technology Background

Chapter 4 Market Drivers

Chapter 5 Market Breakdown By Type

Chapter 6 Market Breakdown By Disease Application

Chapter 7 Market Breakdown By Application Type

Chapter 8 Market Breakdown By Region

Chapter 9 Viral Vector Manufacturing Industry Structure

Chapter 10 Patent Analysis

Chapter 11 Company Profiles

  • Advanced Bioscience Laboratories, Inc.
  • Advanced Biotherapeutics Consulting
  • Applied Viromics
  • Batavia Biosciences
  • Benitec Biopharma
  • Biogen Idec (Now Biogen, Inc.)
  • Biovian
  • Boehringer Ingelheim Gmbh
  • Brammer Bio
  • Cell And Gene Therapy Catapult
  • Ceva Corporate
  • Cobra Biologics (Subsidiary Of Recip Ab)
  • Creative Biogene
  • GE Healthcare
  • Genedetect
  • Genvec Inc. (Subsidiary Of Intrexon Corp.)
  • ID Pharma Co. Ltd.
  • Janssen Pharmaceutical Companies Of Johnson & Johnson
  • Lonza
  • Merck Millipore
  • Miltenyi Biotec
  • Molmed Spa
  • Paragon Bioservices Inc.
  • Pfizer Inc.
  • Sanofi
  • Sementis
  • Spark Therapeutics Inc.
  • Synpromics
  • Valneva
  • Vector Biolabs
  • Vigene Biosciences Inc.
  • Virovek

For more information about this report visit

View source version on

Business Wire

Last updated on: 22/10/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.